Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in three months ended June 30, 2015

The net revenue in Q2 represented an increase of $0.24 million or 1.8 percent from $13 million in the comparable 2014 three month period.

Gross profit was $10.32 million, representing a gross margin of 77.9 percent.

Ms Lianyun Han, CEO, Nutrastar, commented, "For the first half of 2015, we performed in line with our expectations. Sales of our core premium consumer product Cordyceps came in at $17.29 million, up 3.1 percent year-over-year, functional health beverages contributed $1.83 million and organic and specialty foods segment, our third consumer product category, contributing $1.17 million to revenues."

Ms Han continued, "As for the remainder of the year, we are confident in the continuation of our growth and expect to meet our full year 2015 revenue guidance. Demand for our premium consumer products remains steadfast and robust. We remain committed to growing our brand awareness, bringing more products into the hands of health-conscious consumers and expanding our market internationally."

Based on management's current expectations, full year 2015 revenue remains in the range of $43 million to $45 million.